Kidswell Bio (TSE:4584) Total Stockholders Equity: 円1,654 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4584 Kidswell Bio Corp TSE:4584
44 GF Score
Price 円167.00
GF Value 円236.43
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Kidswell Bio Total Stockholders Equity?

Kidswell Bio TSE:4584 -2.91% 44 Total Stockholders Equity is 円1,654 Mil as of Mar. 2026. GuruFocus rates TSE:4584 with a GF Score™ of 44/100 and a GF Value™ of 円236.43 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Kidswell Bio's Total Stockholders Equity for the quarter that ended in Mar. 2026 was 円1,654 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Kidswell Bio's Book Value per Share for the quarter that ended in Mar. 2026 was 円33.33. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Kidswell Bio's Debt-to-Equity for the quarter that ended in Mar. 2026 was 1.54.

Kidswell Bio  (TSE:4584) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Kidswell Bio's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1653.917-0)/49.623
=33.33

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Kidswell Bio's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(362.5 + 2187.5) / 1653.917
=1.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kidswell Bio Total Stockholders Equity Related Terms

Kidswell Bio Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Kidswell Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kidswell Bio Total Stockholders Equity Chart

Kidswell Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,702.91 1,233.51 831.47 1,410.98 1,653.92

Kidswell Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,048.00 2,186.18 1,926.07 1,653.92 1,837.45
TSE:4584
44GF Score
Kidswell Bio Corp TSE:4584
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円1,654 Mil mean?
Kidswell Bio (TSE:4584) has a Total Stockholders Equity of 円1,654 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Kidswell Bio and its competitors.
Is Kidswell Bio's Total Stockholders Equity too high?
Kidswell Bio's current Total Stockholders Equity is 円1,654 Mil. Overall, Kidswell Bio has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's Total Stockholders Equity compare to VRTX and REGN?
Kidswell Bio's Total Stockholders Equity of 円1,654 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Kidswell Bio and its competitors. Kidswell Bio's current Total Stockholders Equity is 円1,654 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Modestly Undervalued. The stock's GF Value™ is 円236.43, compared to a current price of 円167.00 — trading 29.4% below its estimated fair value. The current Total Stockholders Equity is 円1,654 Mil. Kidswell Bio's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current Total Stockholders Equity is 円1,654 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kidswell Bio (TSE:4584) Overvalued in 2026?

Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued. The current stock price of 円167.00 is trading 29.4% below its estimated GF Value™ of 円236.43. GuruFocus considers Kidswell Bio to be Modestly Undervalued.

Key valuation signals for TSE:4584:

  • Total Stockholders Equity: 円1,654 Mil
  • GF Value™: 円236.43 vs. price of 円167.00 (29.4% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kidswell Bio Business Description

Address 1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
44GF Score

Get the complete analysis for TSE:4584

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円167.00
Price
円236.43
GF Value